|
|
Article: Schering-Plough Announces CLARINEX(R) (Desloratadine) Now Available Nationwide for Treatment of Seasonal Allergies; New Once-Daily, Nonsedating Therapy Provides 24-Hour Relief Of Nasal and Non-Nasal Symptoms of Seasonal Allergies.
- Article from:
- PR Newswire
- Article date:
- January 14, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
KENILWORTH, N.J. -- Schering-Plough Corporation announced today that its new nonsedating antihistamine, CLARINEX(R) (desloratadine) 5 mg Tablets, is now available by prescription in pharmacies nationwide for the treatment of seasonal allergic rhinitis (SAR).
Approved by the U.S. Food and Drug Administration (FDA) on Dec. 21, 2001, CLARINEX is a once-daily, nonsedating antihistamine that provides 24-hour relief from the symptoms of SAR in adults and children 12 years of age and older. In clinical trials, CLARINEX Tablets significantly reduced total symptom scores of the nasal and non-nasal symptoms of seasonal allergies.
"With its proven clinical ...